================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) July 29, 2004
HAEMONETICS CORPORATION
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Massachusetts 1-10730 04-2882273
---------------------------- ---------------- -------------------
(State or other jurisdiction (Commission File (IRS Employer
of incorporation) Number) Identification No.)
400 Wood Road Braintree, MA 02184
---------------------------------------- ----------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (781) 848-7100
--------------------------------------------------------------------------------
(Former name or former address if changed since last report)
Item. 7 FINANCIAL STATEMENTS AND EXHIBITS
(c) Exhibits
99.1: Press Release of Haemonetics Corporation dated July 29, 2004
Item. 12 RESULTS OF OPERATIONS AND FINANCIAL CONDITION
On July 29, 2004, Haemonetics Corporation (the "Company") issued a
press release announcing financial results for the first quarter
ended July 3, 2004. A copy of the release is furnished with this
report as exhibit 99.1.
The information in this current report on Form 8-K and the exhibit
attached hereto shall not be deemed "filed" for the purposes of
Section 18 of the Securities and Exchange Act of 1934 (the "Exchange
Act") or otherwise subject to the liabilities of that section, nor
shall it be deemed incorporated by reference in any filing under the
Securities Act of 1933 or the Exchange Act, regardless of any
general incorporation language in such filing.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
(Registrant)
Date: July 29, 2004 By: /s/ Ronald J. Ryan
----------------------------------------
Ronald J. Ryan, Vice President and Chief
Financial Officer
2
EXHIBIT INDEX
Exhibit No. Subject Matter
----------- --------------
99.1 Press Release of Haemonetics Corporation
dated July 29, 2004.
3